Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, will expedite its path to market.
  • @cm0002English
    41•6 days ago

    for patients with locally advanced dMMR/MSI-H rectal cancer

  • @[email protected]English
    11•6 days ago

    We really are living in a future dystopia. This is so cool, but I can’t imagine it’s going to be very accessible

    • @[email protected]English
      7•6 days ago

      Actually, given the cost of multiple radiation or chemo treatments this might be cheaper and thus more favored by insurance, etc.